ReviewJournal of nephrology2025
Hemoadsorption and plasma adsorption: two current options for the 3rd dimension of dialysis purification.
Review in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Extracorporeal Free-Light-Chain Removal in Myeloma Cast Nephropathy: Plasma Exchange and Hemodialysis Strategies in the Era of Effective Antimyeloma Therapy.Journal of clinical medicine · 2026Review
- Dialysis vintage modifies the effect of adsorption-based therapies on protein-bound toxin clearance.Frontiers in cell and developmental biology · 2026Article
- Evaluation of Biocompatible and Biodegradable PES/PCL Membranes for Potential Use in Biomedical Devices: From Fouling Resistance to Environmental Safety.Molecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The adsorption technique has opened a new frontier in the field of purification through hemodialysis. This technique has proved to be effective in removing uremic toxins previously deemed inaccessible due to their size or charge, as well as to their molecular interactions with blood proteins. In this context, this review provides a detailed explanation of the role of Polyester-polymer alloy (PEPA®) membranes and hemodiafiltration with endogenous reinfusion. The polyester-polymer alloy membrane is a three-layered dialysis membrane with adsorbent properties, representing an innovative approach to engineering the filter membrane to achieve adsorbent characteristics while maintaining biocompatibility with blood. Haemodiafiltration with endogenous reinfusion is a technique where a first filter separates plasma water from blood, then plasma water is led to a sorbent cartridge. After contact with the sorbent, the purified plasma water reconstitutes the whole blood, which is led to a second filter where diffusion takes place. Both techniques are efficacious in removing middle-molecular weight molecules and protein-bound toxins, and have a role in reducing inflammation and erythropoietin resistance. However, the additional clinical advantage of adsorption is partially offset by lack of selectivity in the absorption process, potentially resulting in the loss of micro- and macronutrients or drugs. Therefore, further studies are encouraged to evaluate the impact of absorption on patient outcomes and clinical applicability in certain medical conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.